{"url":"https://lda.senate.gov/api/v1/filings/7ac02f0f-0fff-462d-907b-8eb4e6bac321/","filing_uuid":"7ac02f0f-0fff-462d-907b-8eb4e6bac321","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2023,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7ac02f0f-0fff-462d-907b-8eb4e6bac321/print/","filing_document_content_type":"text/html","income":null,"expenses":"460000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Maya J. Bermingham","dt_posted":"2023-04-20T16:50:20-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"777 OLD SAW MILL RIVER ROAD","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"TARRYTOWN","registrant_state":"NY","registrant_zip":"10591","registrant":{"id":401104131,"url":"https://lda.senate.gov/api/v1/registrants/401104131/","house_registrant_id":null,"name":"REGENERON PHARMACEUTICALS, INC","description":"Biopharmaceutical development and manufacturing","address_1":"777 OLD SAW MILL RIVER ROAD","address_2":null,"address_3":null,"address_4":null,"city":"TARRYTOWN","state":"NY","state_display":"New York","zip":"10591","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"MAYA J. BERMINGHAM","contact_telephone":"+1 914-598-3031","dt_updated":"2026-07-29T09:39:25.971423-04:00"},"client":{"id":200807,"url":"https://lda.senate.gov/api/v1/clients/200807/","client_id":12,"name":"REGENERON PHARMACEUTICALS, INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"NY","state_display":"New York","country":"US","country_display":"United States of America","ppb_state":"NY","ppb_state_display":"New York","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-08-01"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare, Medicaid, and other drug pricing issues relating to biopharmaceutical manufacturers","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71871,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"HADDAD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69444,"prefix":null,"prefix_display":null,"first_name":"VALERIE","nickname":null,"middle_name":null,"last_name":"VOLPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140574,"prefix":null,"prefix_display":null,"first_name":"MADDIE","nickname":null,"middle_name":null,"last_name":"DAVIDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140575,"prefix":null,"prefix_display":null,"first_name":"EBEN","nickname":null,"middle_name":null,"last_name":"DUROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent issues relating to biopharmaceutical manufacturers; intellectual property rights; issues related to WTO TRIPS waivers","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":69444,"prefix":null,"prefix_display":null,"first_name":"VALERIE","nickname":null,"middle_name":null,"last_name":"VOLPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140575,"prefix":null,"prefix_display":null,"first_name":"EBEN","nickname":null,"middle_name":null,"last_name":"DUROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140574,"prefix":null,"prefix_display":null,"first_name":"MADDIE","nickname":null,"middle_name":null,"last_name":"DAVIDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Biodefense, FDA, and privacy issues relating to biopharmaceutical manufacturers; tax and incentives; issues related to drug manufacturing and pricing; H.R.5376 - Inflation Reduction Act of 2022; H.R.7900 - National Defense Authorization Act for Fiscal Year 2023; S.954 - Affordable Insulin Now Act of 2023; Consolidated Appropriations Act, 2023; issues related to the Prescription Drug User Fee Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":71871,"prefix":null,"prefix_display":null,"first_name":"KATHERINE","nickname":null,"middle_name":null,"last_name":"HADDAD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":64664,"prefix":null,"prefix_display":null,"first_name":"MAYA","nickname":null,"middle_name":null,"last_name":"BERMINGHAM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69444,"prefix":null,"prefix_display":null,"first_name":"VALERIE","nickname":null,"middle_name":null,"last_name":"VOLPE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140574,"prefix":null,"prefix_display":null,"first_name":"MADDIE","nickname":null,"middle_name":null,"last_name":"DAVIDSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":140575,"prefix":null,"prefix_display":null,"first_name":"EBEN","nickname":null,"middle_name":null,"last_name":"DUROSS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}